Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted Capital Expenditures of $32,000 for Q2 2026, down 13.5% from $37,000 a year earlier but up 113.3% from the prior quarter.
Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Rani Therapeutics Holdings was $47,000, down 80.7% year-over-year; for FY2025, it came in at $88,000, down 67.2% from FY2024.
- Annual Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -40.7% (FY2020 to FY2025).
- In prior years, Rani Therapeutics Holdings' Capital Expenditures was $268,000 in FY2024 (-78.2%), $1.23 million in FY2023 (-24.1%), $1.62 million in FY2022 (+220.0%) and $506,000 in FY2021 (-57.8%).
- Quarterly Capital Expenditures has run from a low of $15,000 in Q1 2026 to a high of $530,000 in Q4 2022 over five years.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last six quarters, with an average decline of 19.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2025, with growth of 183.3%; the weakest was Q1 2024, with a decline of 92.7%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Rani Therapeutics Holdings | 111.44 Mn | -41.89 Mn | - | 183,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 183,000.00 |
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Sep 30, 2023 | 479,000.00 |
| Jun 30, 2023 | 335,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 530,000.00 |
| Sep 30, 2022 | 456,000.00 |
| Jun 30, 2022 | 379,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 271,000.00 |
| Jun 30, 2021 | 136,000.00 |
| Mar 31, 2021 | 99,000.00 |
Rani Therapeutics Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RANI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();